2 insiders reported 6 Form 4 transactions for KYNTRA BIO, INC. (KYNB) over the past 18 months (most recent 2026-06-09). Recent activity: DeLucia David (Chief Financial Officer) Sell 52 shares, Wettig Thane (CEO) Sell 198 shares, Wettig Thane (CEO) Buy 2,800 shares, Wettig Thane (CEO) Sell 2,800 shares, DeLucia David (Chief Financial Officer) Sell 60 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-09 | DeLucia David | Chief Financial Officer | Sell | 52 | $349 |
| 2026-06-09 | Wettig Thane | CEO | Sell | 198 | $1,329 |
| 2026-05-19 | Wettig Thane | CEO | Buy | 2,800 | $19,852 |
| 2026-05-18 | Wettig Thane | CEO | Sell | 2,800 | $19,852 |
| 2026-03-10 | DeLucia David | Chief Financial Officer | Sell | 60 | $410 |
| 2026-03-10 | Wettig Thane | CEO | Sell | 277 | $1,895 |
Source: SEC Form 4 filings · as of 2026-06-09